Benzinga | Feb 26, 2021 09:29AM EST

Genetic Technologies CMO George Muchnicki To Interview On Bloomberg TV Saturday, Feb. 27 At 3 a.m. EST

MELBOURNE, Australia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE) (the "Company"), a leader in the development of genetic risk assessment tests, today announced an interview with Dr. George Muchnicki, Chief Medical Officer and Executive Director, will air on The RedChip Money Report(r) on Bloomberg TV in the US on Saturday, February 27, at 7 p.m. local time in 73M homes across the United States. The RedChip Money Report(r) also airs on Bloomberg International in Europe in 100M homes at 6 pm local time on Sundays.



In the exclusive interview, Dr. Muchnicki discusses the Company's cancer predictive testing and assessment tools to help physicians proactively manage patient health. Also discussed is the global market opportunity, upcoming predictive testing milestones and the capacity for Covid-19 (SDR) serious disease risk testing and the company's developing pipeline of risk assessment products including guideline driven reimbursable Germline panel testing for cancers, heart disease and metabolic diseases such as Type 2 Diabetes.

To view the interview segment, please visit: https://youtu.be/D7Rk9ezrWGM

"The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.